Antioxidant therapy involving either non-specific interventions (e.g. dietary [111]) or targeted approaches (e.g. xanthine oxidase inhibitors [112]), has been widely examined in cardiovascular disease and other disease contexts with both positive and negative findings, however, so far most have failed to confer benefit to all-cause mortality [113]. The gene discussed is XDH; the disease is cardiovascular disorder.